A Validation Study of Adiponectin rs266729 Gene Variant with Type 2 Diabetes, Obesity, and Metabolic Phenotypes in a Taiwanese Population

Biochemical Genetics

Volumn 54, Issue 6, 2016, Pages 830-841

  Hsiao, Tun Jen ^a   Lin, Eugene ^b,c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c VITA GENOMICS INC   (Taiwan)

^d TickleFish Systems Corporation   (United States)

Author keywords

ADIPOQ; Body mass index; Metabolic phenotypes; Obesity; Single nucleotide polymorphisms; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLUCOSE; TRIACYLGLYCEROL; ADIPOQ PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; POLYMERASE CHAIN REACTION SYSTEM; POPULATION; REAL TIME POLYMERASE CHAIN REACTION; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TAIWANESE; VALIDATION STUDY; WAIST CIRCUMFERENCE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; TAIWAN;

ADIPONECTIN; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; VALIDATION STUDIES AS TOPIC;

EID: 84978112693     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-016-9760-y     Document Type: Article

References (44)

1. Ahima RS (2006) Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver Spring) 14(Suppl 1):9S–15S
2. Beebe-Dimmer JL, Zuhlke KA, Ray AM, Lange EM, Cooney KA (2010) Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis 13:362–368
3. Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW (2009) Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 58:499–504
4. Bouatia-Naji N, Meyre D, Lobbens S, Séron K, Fumeron F, Balkau B, Heude B, Jouret B, Scherer PE, Dina C, Weill J, Froguel P (2006) ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55:545–550
5. Chiodini BD, Specchia C, Gori F, Barlera S, D’Orazio A, Pietri S, Crociati L, Nicolucci A, Franciosi M, Signorini S, Brambilla P, Grazia Franzosi M (2010) Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis 4:223–230
6. Chu H, Wang M, Zhong D, Shi D, Ma L, Tong N, Zhang Z (2013) AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. Diabetes Metab Res Rev 29:532–545
7. Cieslak J, Skorczyk A, Stachowiak M, Szydlowski M, Grzes M, Paczynska P, Skowronska B, Majewska K, Stankiewicz W, Fichna P, Switonski M (2011) Polymorphisms in 5′-flanking regions of genes encoding adiponectin, leptin, and resistin are not associated with obesity of Polish children and adolescents. Mol Biol Rep 38:1793–1798
8. Daniele A, Cammarata R, Pasanisi F, Finelli C, Salvatori G, Calcagno G, Bracale R, Labruna G, Nardelli C, Buono P, Sacchetti L, Contaldo F, Oriani G (2008) Molecular analysis of the adiponectin gene in severely obese patients from southern Italy. Ann Nutr Metab 53:155–161
9. Fu T, Wen T, Yeh P, Chang H (2008) Costs of metabolic syndrome-related diseases induced by obesity in Taiwan. Obes Rev 9(Suppl 1):68–73
10. Gable DR, Matin J, Whittall R, Cakmak H, Li KW, Cooper J, Miller GJ, Humphries SE (2007) Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet 71:453–466
11. Gibson F, Froguel P (2004) Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 53:2977–2983
12. Gong M, Long J, Liu Q, Deng HC (2010) Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 325:78–83
13. Gupta V, Khadgawat R, Ng HK, Kumar S, Aggarwal A, Rao VR, Sachdeva MP (2010) A validation study of type 2 diabetes-related variants of the TCF7L2, HHEX, KCNJ11, and ADIPOQ genes in one endogamous ethnic group of north India. Ann Hum Genet 74:361–368
14. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, Legge DG, Quan H, Zhao MM, Ning N, Kang Z, Sun H (2011) Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, −11,377C>G, −11,391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54:2303–2314
15. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536–540
16. Hsiao TJ, Lin E (2014) Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor beta 2 surface gene on obesity and metabolic phenotypes in Taiwan. J Investig Med 62:310–315
17. Hsiao TJ, Lin E (2015) The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population. Endocrine 48:786–793
18. Hsiao TJ, Lin E (2016a) The ENPP1 K121Q polymorphism is associated with type 2 diabetes and related metabolic phenotypes in a Taiwanese population. Mol Cell Endocrinol 433:20–25
19. Hsiao TJ, Lin E (2016b) A common rs7903146 variant of the transcription factor 7 like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population. Diabetes Metab (Epub ahead of print)
20. Hsiao DJ, Wu LS, Huang SY, Lin E (2009) Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenet Genomics 19:730–733
21. Hsiao TJ, Hwang Y, Liu CH, Chang HM, Lin E (2013) Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population. Genes Nutr 8:137–144
22. Hsiao TJ, Hwang Y, Chang HM, Lin E (2014) Association of the rs6235 variant in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene with obesity and related traits in a Taiwanese population. Gene 533:32–37
23. Karmelić I, Lovrić J, Božina T, Ljubić H, Vogrinc Ž, Božina N, Sertić J (2012) Adiponectin level and gene variability are obesity and metabolic syndrome markers in a young population. Arch Med Res 43:145–153
24. Lane HY, Tsai GE, Lin E (2012) Assessing gene-gene interactions in pharmacogenomics. Mol Diagn Ther 16:15–27
25. Li A, Meyre D (2013) Challenges in reproducibility of genetic association studies: lessons learned from the obesity field. Int J Obes (Lond) 37:559–567
26. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188
27. Lin E, Pei D, Huang YJ, Hsieh CH, Wu LS (2009) Gene-gene interactions among genetic variants from obesity candidate genes for nonobese and obese populations in type 2 diabetes. Genet Test Mol Biomarkers 13:485–493
28. Liou YJ, Bai YM, Lin E, Chen JY, Chen TT, Hong CJ, Tsai SJ (2012) Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics. Pharmacogenomics J 12:54–61
29. Lu JF, Zhou Y, Huang GH, Jiang HX, Hu BL, Qin SY (2014) Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis. Hum Immunol 75:1062–1068
30. Olckers A, Towers GW, van der Merwe A, Schwarz PE, Rheeder P, Schutte AE (2007) Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 56:587–592
31. Park JW, Park J, Jee SH (2011) ADIPOQ gene variants associated with susceptibility to obesity and low serum adiponectin levels in healthy Koreans. Epidemiol Health 33:e2011003
32. Populaire C, Mori Y, Dina C, Vasseur F, Vaxillaire M, Kadowaki T, Froguel P (2003) Does the −11,377 promoter variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families? Diabetologia 46:443–445
33. Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V (2013) Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 532:253–262
34. Schwarz PE, Towers GW, van der Merwe A, Perez-Perez L, Rheeder P, Schulze J, Bornstein SR, Licinio J, Wong ML, Schutte AE, Olckers A (2009) Global meta-analysis of the C-11,377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives. Pharmacogenomics J 9:42–48
35. Sun H, Gong ZC, Yin JY, Liu HL, Liu YZ, Guo ZW, Zhou HH, Wu J, Liu ZQ (2008) The association of adiponectin allele 45T/G and −11,377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. Br J Clin Pharmacol 65:917–926
36. Suriyaprom K, Phonrat B, Namjuntra P, Harnroongroj T, Tungtrongchitr R (2010) The −11,377C > G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais. Int J Vitam Nutr Res 80:216–224
37. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Leprêtre F, Dupont S, Hara K, Clément K, Bihain B, Kadowaki T, Froguel P (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607–2614
38. Vasseur F, Meyre D, Froguel P (2006) Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med 8:1–12
39. Wang X, Zhang S, Chen Y, Liu H, Lan C, Chen X, Chi S, Chen S, Zhang W (2009) APM1 gene variants −11,377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes. Diabetes Res Clin Pract 84:205–210
40. Wang Y, Zhang D, Liu Y, Yang Y, Zhao T, Xu J, Li S, Zhang Z, Feng G, He L, Xu H (2009) Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. J Genet Genomics 36:417–423
41. Wang CH, Ke WS, Lin E (2012) Evaluation of the ENPP1 and PLIN single nucleotide polymorphisms with type 2 diabetes in a Taiwanese population: evidence for replication and gene-gene interaction. J Investig Med 60:1169–1173
42. Wu LS, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E (2009) Association and interaction analyses of genetic variants in ADIPOQ, ADIPOQ, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 24:3360–3366
43. Yang M, Qiu CC, Chen W, Xu LL, Yu M, Xiang HD (2008) Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality. Biomed Environ Sci 21:454–459
44. Ziemke F, Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91:258S–261S